Treace Medical Q3 2026 Revenue $48.3M; Net Loss Improved 23%
Treace Medical reported Q3 revenue of $48.3 million and a $12.6 million net loss, demonstrating 23% improved profitability and accelerated double-digit procedure volume growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed